Development, screening, and analysis of DNA aptamer libraries potentially useful for diagnosis and passive immunity of arboviruses

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Bruno, John G ^a   Carrillo, Maria P ^a   Richarte, Alicia M ^a   Phillips, Taylor ^a   Andrews, Carrie ^a   Lee, John S ^b  

^a Operational Technologies Corporation   (United States)

^b U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

Author keywords

Aptamer; Arbovirus; Consensus; DNA; Enzyme linked; Fluorescence; Lateral flow; SELEX

Indexed keywords

ARBOVIRUS; BACTERIA (MICROORGANISMS); IXODIDA; RICKETTSIA; WEST NILE VIRUS;

APTAMER; VIRUS PROTEIN;

ARBOVIRUS; ARTICLE; CHROMATOGRAPHY; COMBINATORIAL CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; SPECTROPHOTOMETRY; VIROLOGY; VIRUS INFECTION;

APTAMERS, NUCLEOTIDE; ARBOVIRUS INFECTIONS; ARBOVIRUSES; BASE SEQUENCE; CHROMATOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; HUMANS; IMMUNIZATION, PASSIVE; MOLECULAR SEQUENCE DATA; SELEX APTAMER TECHNIQUE; SPECTROPHOTOMETRY; VIRAL PROTEINS;

EID: 84868663888     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-633     Document Type: Article

References (30)

1. Use of magnetic beads in selection and detection of biotoxin aptamers by ECL and enzymatic methods. Bruno JG, Kiel JL, Biotechniques 2002 32 178 182 11808691
2. Discrimination of recombinant from natural human growth hormone using DNA aptamers. Bruno JG, Carrillo MP, Phillips T, Edge A, J Biomolec Techn 2011 22 27 36
3. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. Jeon SH, Kayhan B, Ben-Yedidia T, Arnon R, J Biol Chem 2004 279 48410 48419 10.1074/jbc.M409059200 15358767 (Pubitemid 39540998)
4. Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX. Cheng C, Dong J, Yao L, Chen A, Jia R, Huan L, Guo J, Shu Y, Zhang Z, Biochem Biophys Res Comm 2009 366 670 674
5. Selection of an antiviral RNA aptamer against hemagglutinin of the subtype H5 avian influenza virus. Park SY, Kim S, Yoon H, Kim KB, Kalme SS, Oh S, Song CS, Kim DE, Nucleic Acid Ther 2011 21 395 402 22017542
6. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES. Kikuchi K, Umehara T, Nishikawa F, Fukuda K, Hasegawa T, Nishikawa S, Biochem Biophys Res Comm 2009 386 118 123 10.1016/j.bbrc.2009.05.135 19501043
7. Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. Ellenbecker M, Sears L, Li P, Lanchy JM, Stephen Lodmell J, Antiviral Res 2012 93 330 339 10.1016/j.antiviral.2012.01.002 22252167
8. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1. Dey AK, Griffiths C, Lea SM, James W, RNA 2005 11 873 884 10.1261/rna.7205405 15923374 (Pubitemid 40994198)
9. Pharmacokinetics and biodistribution of novel aptamer compositions. Healy JM, Lewis SD, Kurz M, Boomer RM, Thompson KM, Wilson C, McCauley TG, Pharm Res 2004 21 2234 2246 10.1007/s11095-004-7676-4 15648255 (Pubitemid 40568437)
10. Nucleic acid aptamers for target validation and therapeutic applications. Pendergrast PS, Marsh HN, Grate D, Healy JM, Stanton M, J Biomolec Techn 2005 16 224 234
11. Co-infections with Chikungunya virus and dengue virus in Delhi, India. Chahar HS, Bharaj P, Dar L, Guleria R, Kabra SK, Broor S, Emerg Infect Dis 2009 15 1077 1080 10.3201/eid1507.080638 19624923
12. International diagnostic accuracy study for the serological detection of Chikungunya virus infection. Niedrig M, Zeller H, Schuffenecker I, Drosten C, Emmerich P, Rumer L, Donoso-Mantke O, Clin Microbiol Infect 2009 15 880 884 10.1111/j.1469-0691.2009.02851.x 19624513
13. Appearance of E1:A226V mutant Chikungunya virus in coastal Karnataka, India during 2008 outbreak. Santhosh SR, Dash PK, Parida M, Khan M, Rao PV, Virology J 2009 6 172 178 10.1186/1743-422X-6-172
14. Crimean-Congo Hemorrhagic Fever. Whitehouse CA, Antiviral Res 2004 64 145 160 15550268 (Pubitemid 39506835)
15. Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo Hemorrhagic Fever virus. Ahmed AA, McFalls JM, Hoffmann C, Filone CM, Stewart SM, Paragas J, Khodjaev S, Shermukhamedova D, Schmaljohn CS, Doms RW, Bertolotti-Ciarlet A, J Gen Virol 2005 86 3327 3336 10.1099/vir.0.81175-0 16298978 (Pubitemid 41685165)
16. Identification of a novel C-terminal cleavage of Crimean-Congo Hemorrhagic Fever virus PreGN that leads to generation of an NSM protein. Altamura LA, Bertolotti-Ciarlet A, Teigler J, Paragas J, Schmaljohn CS, Doms RW, J Virol 2007 81 6632 6642 10.1128/JVI.02730-06 17409136 (Pubitemid 46878067)
17. Tick-borne encephalitis virus genome: the nucleotide sequence coding for virion structural proteins. Pletnev AG, Yamshchikov VF, Blinov VM, FEBS Lett 1986 200 317 321 10.1016/0014-5793(86)81160-7 3709796
18. An accelerated schedule for tick-borne encephalitis vaccine: the American military experience in Bosnia. Craig SC, Pittman PR, Lewis TE, Rossi CA, Henchal EA, Kuschner RA, Martinez C, Kohlhase KF, Cuthie JC, Welch GE, Sanchez JL, Am J Trop Med Hyg 1999 61 874 878 10674662 (Pubitemid 30084105)
19. Present and future arboviral threats. Weaver SC, Reisen WK, Antiviral Res 2010 85 328 345 10.1016/j.antiviral.2009.10.008 19857523
20. Recent advancement in flavivirus vaccine development. Chang GJ, Kuno G, Purdy DE, Davis BS, Expet Rev Vaccine 2004 3 199 220 10.1586/14760584.3.2.199 (Pubitemid 38470529)
21. Advances in flavivirus vaccine development. Coller BA, Clements DE, Martyak T, Yelmene M, Thorne M, Parks DE, IDrugs 2010 13 880 884 21154147
22. Recent advances in flavivirus antiviral drug discovery and vaccine development. Ray D, Shi PY, Recent Pat Anti-infect Drug Discov 2006 1 45 55 10.2174/157489106775244055
23. The development of flavivirus vaccines. Pulmanausahakul R, Khakpoor A, Smith DR, African J Biotechnol 2010 9 409 415
24. A simple and sensitive dipstick test in serum based on lateral flow separation of aptamer-linked nanostructures. Liu J, Mazumdar D, Lu Y, Ang Chem Int Ed 2006 45 1 5 10.1002/anie.200690000
25. Aptamer-functionalized gold nanoparticles as probes in a dry-reagent strip biosensor for protein analysis. Xu H, Mao X, Zeng Q, Wang S, Kawde AN, Liu G, Anal Chem 2009 81 669 675 10.1021/ac8020592 19072289
26. Vienna RNA secondary structure server. Hofacker IL, Nucleic Acids Res 2003 31 3429 3431 10.1093/nar/gkg599 12824340 (Pubitemid 37442172)
27. Bioinformatic analysis of the contribution of primer sequences to aptamer structures. Cowperthwaite MC, Ellington AD, J Mol Evol 2008 67 95 102 10.1007/s00239-008-9130-4 18594898
28. DNA aptamer beacon assay for C-telopeptide and handheld fluorometer to monitor bone resorption. Bruno JG, Carrillo MP, Phillips T, Hanson D, Bohmann JA, J Fluoresc 2011 21 2021 2033 10.1007/s10895-011-0903-6 21643742
29. Competitive FRET-aptamer-based detection of methylphosphonic acid: a common nerve agent metabolite. Bruno JG, Carrillo MP, Phillips T, Vail NK, Hanson D, J Fluoresc 2008 18 867 876 10.1007/s10895-008-0316-3 18224427
30. Reovirus detection using immunomagnetic-fluorescent nanoparticle sandwich assays. Bruno JG, Francis K, Ikanovic M, Rao P, Dwarakanath S, Rudzinski W, J Bionanosci 2007 1 84 89 10.1166/jbns.2007.015